Physician

Kyle Varvel, M.D.

According to 2025 Medicare claims, Kyle Varvel, M.D. (NPI: 1730316076) practices ophthalmology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is TEXAS REGIONAL EYE CENTER PLLC (NPI: 1790855898; TIN: 710967941) and primary practice location at 77802-6107.

Varvel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 942 traditional Medicare patients, billed 3,555 HCPCS/CPT codes, and received $310,769 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,521 prescription claims across 417 beneficiaries totaling $277,782 in drug costs, led by Restasis (Cyclosporine). 2022 DME data shows 27 claims. Open Payments data shows 26 records totaling $644. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $137,974 to $310,769. Similarly, Part D prescription costs have moved sharply higher in recent years, from $69,066 to $277,782. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	598	1,252	$137,974
2016	707	1,702	$188,446
2017	747	1,808	$193,119
2018	839	2,290	$223,295
2019	878	2,713	$279,105
2020	908	2,756	$257,473
2021	1,184	4,136	$375,595
2022	1,166	3,919	$320,945
2023	1,117	3,712	$294,458
2024	942	3,555	$310,769

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	168	509	$69,066
2016	155	566	$66,663
2017	146	517	$72,925
2018	201	695	$93,302
2019	245	896	$123,026
2020	275	955	$176,649
2021	363	1,169	$227,485
2022	362	1,338	$263,552
2023	412	1,526	$293,428
2024	417	1,521	$277,782

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	38	38	$1,998
2016	59	59	$2,874
2017	44	44	$2,121
2018	41	41	$2,184
2019	49	49	$2,580
2020	N/R	N/R	N/R
2021	43	43	$2,367
2022	27	27	$1,233
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	179	314	$352
92014	Established patient complete exam of visual system	748	805	$74
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	179	317	$40
92134	Imaging of retina	386	405	$26
92250	Photography of the retina	227	231	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	80	4,980	$100,531
Xiidra	Lifitegrast	33	2,670	$54,843
Cyclosporine	Cyclosporine	47	3,315	$27,745
Lumigan	Bimatoprost	39	2,012	$16,927
Vyzulta	Latanoprostene Bunod	29	1,831	$13,373

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$644	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kyle Varvel, M.D.?

Tedicare shows public-source Medicare data for Kyle Varvel, M.D. (NPI 1730316076), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kyle Varvel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kyle Varvel, M.D.?

Kyle Varvel, M.D. is linked to TEXAS REGIONAL EYE CENTER PLLC (billing NPI 1790855898) in the available physician profile data.

Does Kyle Varvel, M.D. have Open Payments data?

Kyle Varvel, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.